Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
		
    
        
        Comparative analysis of the effects of radiotherapy versus radiotherapy after adjuvant chemotherapy on the composition of lymphocyte subpopulations in breast cancer patients.
    
        
        Radiother. Oncol. 118, 176-180 (2016)
    
    
    
				BACKGROUND: Breast cancer is the most common cancer in women worldwide and surgery, radiotherapy (RT) and chemotherapy (ChT) are frequently used to treat this cancer. Adjuvant RT has been shown to cause long-term changes in lymphocyte counts in the peripheral blood. Herein, the time course of changes in lymphocyte subpopulations upon RT was studied in patients with and without adjuvant ChT in order to explore its potential clinical impact. MATERIALS AND METHODS: Total lymphocyte counts and the composition of lymphocyte subpopulations before RT (t0), after 30Gy (t1), at the end of RT (t2), and 6weeks (t3), 6months (t4), and 1year (t5) after RT were studied by flow cytometry. RESULTS: Absolute lymphocyte counts were significantly lower in all breast cancer patients (n=40) before and also 1year after RT compared to healthy controls. The percentage of CD3(+)/CD4(+) helper T cells and FoxP3(+) regulatory T cells increased significantly in patients without adjuvant ChT. Different NK cell subpopulations dropped during RT in patients with and without ChT, but recovered to initial levels 6months after RT (t4). During RT (t0-t2) the percentage of CD19(+) B cells significantly dropped in patients without ChT, but gradually increased in patients with adjuvant ChT. Both patient groups reached initial levels 6months after RT (t4). CONCLUSION: Different lymphocyte subpopulations respond differently to RT with and without adjuvant ChT. CD4(+) T cells increase during RT, whereas NK cells and B cells decrease in patients without ChT, but recover within 6months after RT. Treg cells gradually increase in patients without ChT from t0 to t5, but not in patients with adjuvant ChT.
			
			
		Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Times Cited
Scopus
Cited By
					
					Cited By
Altmetric
					
				4.817
					1.555
					27
					28
					
					
				Anmerkungen
				
					
						 
						
					
				
			
				
			
				Besondere Publikation
				
					
						 
					
				
			
			
			
				Auf Hompepage verbergern
				
					
						 
					
				
			
			
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
     
    
    
        Schlagwörter
        Breast Cancer ; Chemotherapy ; Lymphocyte Subpopulations ; Radiotherapy; Regulatory T-cells; Peripheral-blood; Immune Function; Microenvironment; Carcinoma; Counts; System
    
 
     
    
    
        Sprache
        
    
 
    
        Veröffentlichungsjahr
        2016
    
 
     
    
        HGF-Berichtsjahr
        2016
    
 
    
    
        ISSN (print) / ISBN
        0167-8140
    
 
    
        e-ISSN
        1879-0887
    
 
     
     
     
	     
	 
	 
    
        Zeitschrift
        Radiotherapy and Oncology
    
 
		
    
        Quellenangaben
        
	    Band: 118,  
	    Heft: 1,  
	    Seiten: 176-180 
	    
	    
	
    
 
  
         
        
            Verlag
            Elsevier
        
 
        
            Verlagsort
            Clare
        
 
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Begutachtungsstatus
        Peer reviewed
    
 
    
        Institut(e)
        Institute of Radiation Medicine (IRM)
    
 
    
        POF Topic(s)
        30203 - Molecular Targets and Therapies
    
 
    
        Forschungsfeld(er)
        Radiation Sciences
    
 
    
        PSP-Element(e)
        G-501300-001
G-501390-001
 
     
     	
    
    G-501390-001
        WOS ID
        WOS:000371551100028
    
    
        PubMed ID
        26683801
    
    
        Erfassungsdatum
        2016-02-16